[HTML][HTML] Role and regulation of autophagy in cancer
R Rakesh, LC PriyaDharshini, KM Sakthivel… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Autophagy is an intracellular self-degradative mechanism which responds to cellular
conditions like stress or starvation and plays a key role in regulating cell metabolism, energy …
conditions like stress or starvation and plays a key role in regulating cell metabolism, energy …
[HTML][HTML] Recent advances in drug delivery systems for targeting cancer stem cells
H Duan, Y Liu, Z Gao, W Huang - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Cancer stem cells (CSCs) are a subpopulation of cancer cells with functions similar to those
of normal stem cells. Although few in number, they are capable of self-renewal, unlimited …
of normal stem cells. Although few in number, they are capable of self-renewal, unlimited …
Neutrophil extracellular traps (NETs) and damage‐associated molecular patterns (DAMPs): two potential targets for COVID‐19 treatment
S Cicco, G Cicco, V Racanelli… - Mediators of …, 2020 - Wiley Online Library
COVID‐19 is a pandemic disease caused by the new coronavirus SARS‐CoV‐2 that mostly
affects the respiratory system. The consequent inflammation is not able to clear viruses. The …
affects the respiratory system. The consequent inflammation is not able to clear viruses. The …
Cancer stem cells: A brief review of the current status
Cancer stem cells (CSCs) comprise the subpopulation of tumor bulk and acquire resistant to
conventional therapies and are considered as the primary tumor initiator cells. Nowadays …
conventional therapies and are considered as the primary tumor initiator cells. Nowadays …
[HTML][HTML] Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
C Verbaanderd, H Maes, MB Schaaf… - …, 2017 - ncbi.nlm.nih.gov
Chloroquine (CQ) and hydroxychloroquine (HCQ) are well-known 4-aminoquinoline
antimalarial agents. Scientific evidence also supports the use of CQ and HCQ in the …
antimalarial agents. Scientific evidence also supports the use of CQ and HCQ in the …
Treatment strategies against triple-negative breast cancer: an updated review
Triple-negative breast cancer (TNBC) is associated with an increased risk of early
recurrence and distant metastasis, as well as the development of therapeutic resistance and …
recurrence and distant metastasis, as well as the development of therapeutic resistance and …
Hydroxychloroquine in rheumatic autoimmune disorders and beyond
EL Nirk, F Reggiori, M Mauthe - EMBO molecular medicine, 2020 - embopress.org
Initially used as antimalarial drugs, hydroxychloroquine (HCQ) and, to a lesser extent,
chloroquine (CQ) are currently being used to treat several diseases. Due to its cost …
chloroquine (CQ) are currently being used to treat several diseases. Due to its cost …
Emerging agents that target signaling pathways in cancer stem cells
Y Yang, X Li, T Wang, Q Guo, T Xi, L Zheng - Journal of hematology & …, 2020 - Springer
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …
however, there are still no drugs targeting CSCs in clinical application. There are several …
DNMT1: A key drug target in triple-negative breast cancer
KK Wong - Seminars in cancer biology, 2021 - Elsevier
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer.
Altered epigenetics regulation including DNA hypermethylation by DNA methyltransferase 1 …
Altered epigenetics regulation including DNA hypermethylation by DNA methyltransferase 1 …
Targeting autophagy in breast cancer
S Cocco, A Leone, M Piezzo, R Caputo… - International journal of …, 2020 - mdpi.com
Breast cancer is a heterogeneous disease consisting of different biological subtypes, with
differences in terms of incidence, response to diverse treatments, risk of disease …
differences in terms of incidence, response to diverse treatments, risk of disease …